Patient-centered factors include comorbidities (established ASCVD or indicators of high-risk established kidney disease, or heart failure), the presence of a compelling need to minimize hypoglycemia, the need to promote weight loss or minimize weight gain, and cost [15, 17]
Patients should aim for adequate fluid intake throughout the day, using small, frequent sips if large volumes are not tolerated
Medications like Ozempic , Wegovy , and Mounjaro have changed the landscape of weight loss
If you plan to microdose, a 10mg/mL vial provides better precision at these small volumes
If tirzepatide has stalled your progress and you have significant weight loss remaining, the case is strongpending cardiovascular clearance and full regulatory approval